✅ Model Answer:
• Diagnosis: Post-obstructive nephrogenic diabetes insipidus — chronic obstruction (posterior urethral valves) causes tubular damage and impaired concentrating ability. Hypernatremia (150 mEq/L), dilute urine (120 mOsm/kg), no DDAVP response (urine osm 130 → 140, <50% rise). Normal glucose excludes DM. History of PUV and post-valvotomy is the key clue.
• Any other test: Renal function (creatinine, BUN), urinalysis (proteinuria, hematuria), renal ultrasound (hydronephrosis, cortical thinning, echogenicity), VCUG (to assess for residual obstruction), urine electrolytes.
• What to do next: Ensure complete relief of obstruction. Manage NDI with thiazide diuretic (hydrochlorothiazide 1-2 mg/kg/day) + amiloride (0.3-0.5 mg/kg/day). Low-sodium diet. Monitor hydration status.
• Follow-up plan: Monitor renal function, growth, blood pressure. Screen for chronic kidney disease. Urology and nephrology follow-up.

✅ Model Answer:
• Pathophysiology: Chronic urinary obstruction (e.g., posterior urethral valves) causes:
- Increased intrarenal pressure: Back-pressure from obstruction → hydronephrosis → tubular damage.
- Tubulointerstitial injury: Chronic inflammation, fibrosis, and scarring of the renal tubules and interstitium.
- Medullary damage: The renal medulla is particularly vulnerable → impaired concentrating ability.
- Decreased aquaporin-2 (AQP2) expression: Collecting duct dysfunction → ADH resistance.
- Nephrogenic DI: Kidneys cannot concentrate urine despite normal ADH levels (or elevated ADH).
• Risk factors: Duration of obstruction, degree of hydronephrosis, recurrent UTIs.
• Reversibility: May be partially reversible if obstruction is relieved early; chronic damage may be permanent.

✅ Model Answer:
• Complications:
- Obstructive uropathy: Bilateral hydronephrosis, hydroureter.
- Chronic kidney disease (CKD): Progressive renal impairment → ESRD in 20-30% of patients.
- Nephrogenic DI: Impaired concentrating ability (polyuria, polydipsia).
- Vesicoureteral reflux (VUR): High-grade VUR in 50-60% of patients.
- Urinary tract infections (UTIs): Increased risk due to urinary stasis and instrumentation.
- Hypertension: Due to renal dysfunction and hypervolemia.
- Proteinuria: Glomerular damage (can be nephrotic range).
- Renal dysplasia: Congenital renal parenchymal abnormalities.
- Bladder dysfunction: Myogenic bladder, detrusor overactivity.

✅ Model Answer:
• VCUG (voiding cystourethrogram): The gold standard for diagnosing posterior urethral valves.
• Findings:
- Dilated posterior urethra: "Spinning top" appearance.
- Valve leaflets: Seen as filling defects in the urethra.
- Hydronephrosis: Dilated renal pelvises and calyces.
- VUR: Vesicoureteral reflux (often high-grade).
- Bladder trabeculation: Thickened bladder wall (due to chronic obstruction).
- Post-void residual: Incomplete bladder emptying.
• Indications:
- All male neonates with hydronephrosis, poor urinary stream, or UTI.
- After valvotomy, to assess for residual obstruction or VUR.
- To monitor bladder function and guide management.
• Timing: Usually performed after stabilization of the neonate (within the first few days of life).

✅ Model Answer:
• Ensure complete relief of obstruction:
- Valvotomy (ablation of valves): Primary treatment for PUV.
- Vesicostomy: Temporary urinary diversion if the infant is unstable.
- Posterior urethral valve ablation: Endoscopic resection of the valve leaflets.
• Pharmacological therapy for NDI:
- Thiazide diuretic (hydrochlorothiazide): 1-2 mg/kg/day (paradoxically reduces urine output).
- Amiloride: 0.3-0.5 mg/kg/day (potassium-sparing, prevents hypokalemia).
- Low-sodium diet: Reduces urine volume.
- Indomethacin: 2 mg/kg/day (if severe, monitor renal function).
• Hydration: Ensure free water access to prevent hypernatremia.
• Avoid: Dehydration, NSAIDs (can worsen renal function).
• Monitor: Serum sodium, potassium, renal function, urine output.

✅ Model Answer:
• Complications:
- Hypernatremia: Severe dehydration → seizures, coma, death.
- Chronic kidney disease (CKD): Progressive renal impairment → ESRD.
- Growth failure: Due to poor weight gain and chronic dehydration.
- Recurrent UTIs: Due to urinary stasis and VUR.
- Hypertension: Due to renal dysfunction and hypervolemia.
- Proteinuria: Progressive glomerular damage.
- Bladder dysfunction: Myogenic bladder, incontinence.
- Electrolyte imbalances: Hypokalemia (with thiazide therapy), hyperkalemia (if amiloride is not used).
- Death: Rare, but possible if untreated hypernatremia or ESRD.

✅ Model Answer:
• Renal ultrasound: Essential for monitoring renal structure and function in patients with PUV.
• Findings:
- Hydronephrosis: Dilated renal pelvises and calyces (graded mild to severe).
- Cortical thinning: Loss of renal parenchyma (chronic obstruction).
- Increased echogenicity: Renal cortical scarring.
- Small kidneys: Atrophic changes (end-stage).
- Bladder wall thickening: Trabeculation (chronic obstruction).
- Post-void residual: Incomplete bladder emptying.
• Indications:
- All neonates with PUV (prenatal and postnatal).
- Follow-up imaging to monitor for progression of hydronephrosis.
- If renal function declines or symptoms worsen.
• Frequency: Every 3-6 months in the first year, then annually if stable.

✅ Model Answer:
• Prognosis:
- Variable: Depends on the severity and duration of obstruction, and the degree of renal damage at the time of diagnosis.
- NDI: May be partially reversible if obstruction is relieved early; chronic damage may be permanent.
- Renal function: 20-30% of patients with PUV progress to ESRD by adolescence/adulthood.
- Creatinine nadir: The lowest creatinine level after relief of obstruction is the best predictor of long-term renal function.
- Growth: May improve with adequate hydration and nutrition.
- Bladder function: May require clean intermittent catheterization (CIC) if bladder dysfunction persists.
- Life expectancy: Reduced in patients who develop ESRD.
• Long-term follow-up:
- Nephrology: Regular monitoring of renal function, blood pressure, and proteinuria.
- Urology: Long-term surveillance for bladder dysfunction, UTIs, and residual obstruction.
- Growth: Monitor weight and height.
- Education: Teach family about the importance of hydration, recognition of dehydration signs, and medication adherence.
- Transition to adult care: Prepare for transition to adult nephrology and urology.